The Chinese heart valve device market will experience robust growth through 2024, driven by an aging population and the adoption of THV devices.

中国的人工心脏瓣膜市场，由人口的高龄化和经导管心脏瓣膜(THV)的引进所促进，预计到2024年坚实成长。